| Health / Medical Topics |
Human Papillomavirus 16 E7 Peptide
A peptide vaccine consisting of amino acids 12 through 20 of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for HPV-16 E7, resulting in decreased tumor growth. HPV-16 infection is tumorigenic and highly associated with cervical cancer. (NCI Thesaurus)
YOU MAY ALSO LIKE
A type of virus that can cause abnormal tissue growth (for example, warts) and other changes to cells. Infection for a long…
A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation.
A vaccine formulation consisting of several types of human papillomavirus (HPV)-derived noninfectious virus-like particles (VLPs) with potential immunoprophylactic activity. Upon administration, HPV…
The process of manufacturing non-prescription medications for humans by a pharmaceutical company.
The process of distributing non-prescription medications for human use.
Early-to late-stage myeloid progenitor cells derived from adult human stem cells with potential hematopoietic activity. Upon infusion, human myeloid progenitor cells CLT-008…
